Shobha Shukla - CNS
While the currently available HIV prevention and treatment tools have helped reduce new HIV infections and AIDS-related deaths by 23% and 39% respectively since 2010, we still have a long way to go before ending this epidemic. With 1.7 million new HIV infections and 690,000 AIDS-related deaths in 2019, one cannot but over emphasise the urgent need to have more HIV prevention options, including long-acting HIV prevention strategies that might prove to be more acceptable and user friendly to people from diverse communities.
Topping the list is the much-awaited long-acting dapivirine vaginal ring that has finally seen the light of the day and is under regulatory approval processes of several countries. This long acting female oriented HIV prevention option is designed to be used by women discreetly. It is a silicon ring impregnated with dapivirine which a woman can insert in her vagina and be protected from acquiring HIV for 28 days at a time. The ring has to b
Image: PBS
PBS special to feature three Behrend faculty members
Online forum will be part of Erie screening of ‘The Gene: An Intimate History’ February 1, 2021
The Erie screening of “The Gene: An Intimate History,” a two-part PBS documentary by Ken Burns, will include a panel discussion featuring three Penn State Behrend faculty members.
The screening and discussion will be livestreamed, beginning at 7 p.m. on Wednesday, Feb. 3. To register, visit wqln.org/gene.
“The Gene: An Intimate History” will be broadcast in its entirety on Feb. 4 and Feb. 11 on WQLN-TV. The four-hour series uses science, social history and personal narratives to tell the story of the human genome. It begins with Gregor Mendel, the Austrian monk who discovered, while working in his garden, that peas – and people – have dominant and recessive traits.
90-day vaginal ring may effectively prevent both HIV and pregnancy medicaldialogues.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicaldialogues.in Daily Mail and Mail on Sunday newspapers.
Vaginal Ring Holds Potential in Preventing HIV and Pregnancy by Angela Mohan on January 27, 2021 at 3:23 PM
Vaginal ring containing Dapivirine and levonorgestrel delivered sustained levels of drugs when used continuously for 90 days, levels likely sufficient to serve dual purpose for protecting against both HIV and unwanted pregnancy.
Results of the Phase I study of the 90-day dual-purpose ring are being presented at the HIV Research for Prevention (HIVR4P) Virtual Conference, or HIVR4P Virtual, which is taking place over the course of four days.
The study, MTN-044/IPM 053/CCN019, was conducted by researchers from the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN) in collaboration with NIH s Contraceptive Clinical Trials Network (CCTN) and is the first to evaluate the ring s use, as intended, for 90 days.
E-Mail
PITTSBURGH, 26 January 2021 - A vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel delivered sustained levels of each drug when used continuously for 90 days - levels likely sufficient to serve its dual purpose for protecting against both HIV and unwanted pregnancy, according to findings of a new study.
Results of the Phase I study of the 90-day dual-purpose ring are being presented at the HIV Research for Prevention (HIVR4P) Virtual Conference, or HIVR4P // Virtual, which is taking place over the course of four days: Jan. 27-28 and Feb. 3-4.
The study, MTN-044/IPM 053/CCN019, was conducted by researchers from the National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN) in collaboration with NIH s Contraceptive Clinical Trials Network (CCTN) and is the first to evaluate the ring s use, as intended, for 90 days. In an earlier first-in-human study (MTN-030/IPM 041), also conducted by the MTN, women use